2 assets in APP-Related Brain And Vascular Amyloidosis

Therapeutic assets addressing APP-Related Brain And Vascular Amyloidosis, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Donanemab APP-Related Brain And Vascular Amyloidosis	Michael Rafii, MD, PhD	P4	BB (65)
Aci-24.060 APP-Related Brain And Vascular Amyloidosis	AC Immune SA	P1/2	NR ()